“Unintended consequences” for prescribing software with move to AIP

Australia's two leading general practice clinical software vendors are reporting teething problems with the introduction of active ingredient prescribing (AIP), with confusion over the lists of medicines that are excluded from the new rules and those where using both active ingredient and brand name is still recommended.

Pharmacy groups are also reporting problems with prescriptions, including complaints that the intention of the prescriber is sometimes unclear and that listing ingredients alphabetically is leading to confusion about dosage.

New rules requiring that doctors prescribe by active ingredient rather than brand became mandatory on February 1 but Pulse+IT sources say some prescribers were unaware of the changes.

Posted in Australian eHealth

Tags: MedicalDirector, Best Practice, MIMS, Pharmacy Guild, active ingredient prescribing

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2021 Pulse+IT Communications Pty Ltd
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.
Supported by Social Media Agency | pepperit